The longest animal studies on BPC-157 span approximately 4 weeks to 12 weeks, leaving the safety profile for use extending beyond 3 months entirely undocumented in peer-reviewed literature
The neuroprotective properties of this nootropic agent help protect neurons from lactocidosis by preventing the formation of free radicals and have been studied in Parkinsons disease, Alzheimers disease, MS, ALS, TBI, and stroke
B12 shots have also been used to enhance athletic performance and treat heart disease, osteoporosis, and anemia
Some of the side effects of Zecobax-12 Injection are gastrointestinal disturbance and decreased white blood cell count
BPC 157 is usually discussed more for soft-tissue recovery than for regular post-workout soreness
Following administration of a combined oral contraceptive (0.035 mg ethinyl estradiol and 0.25 mg norgestimate) in the presence of a single dose of tirzepatide 5 mg, mean Cmax of ethinyl estradiol, norgestimate, and norelgestromin was reduced by 59%,66%, and 55%, while mean AUC was reduced by 20%, 21%, and 23%, respectively